Kura Oncology, Inc. (KURA) Financials

KURA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 448.9 million 51.7 million
2023-09-30 473.8 million 43.8 million
2023-06-30 494.7 million 11.2 million
2023-03-31 426.0 million 30.8 million

KURA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -34.3 million 7.2 million
2023-09-30 -29.0 million 7.1 million
2023-06-30 -25.7 million 7.0 million
2023-03-31 -35.9 million 6.8 million

KURA Net Income

No data available :(

KURA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 424.0 million - 7.9 million
2023-09-30 452.6 million - 8.1 million
2023-06-30 477.0 million - 3.8 million
2023-03-31 405.9 million 9.2 million 4.3 million

KURA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 77.3 million
2023-09-30 77.2 million
2023-06-30 69.8 million
2023-03-31 68.4 million

KURA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 16000 32.5 million 14.2 million 214000
2023-09-30 20000 29.3 million 13.1 million -
2023-06-30 96000 28.2 million 11.8 million -
2023-03-31 36000 25.2 million 11.4 million -

KURA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.3 million 214000
2023-09-30 - 216000
2023-06-30 - 213000
2023-03-31 - 206000

KURA

Price: $20.28

52 week price:
7.41
24.17

Earnings Per Share: -2.08 USD

P/E Ratio: -10.46

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 495600

Ebitda: -9.1 million

Market Capitalization: 1.6 billion

Links: